Publication Ethics and Malpractice Statement

The International Journal of Pharmaceutical Science and Medicine is committed to upholding the highest standards of publication ethics. We aim to ensure that all content published in our journal is of the highest scientific quality, fully transparent, and ethically sound. Below are the ethical guidelines, copyright policies, and the licensing terms for authors, reviewers, and editors involved in the publication process.

1. Publication and Authorship

• Originality: Authors must submit only original work that has not been published elsewhere and must avoid plagiarism of any kind. All manuscripts are screened using plagiarism detection tools.

• Authorship: Only those who have made significant contributions to the conception, design, execution, or interpretation of the research are eligible to be listed as authors. All authors must approve the final manuscript.

• Acknowledgment of Sources: Authors must properly acknowledge all sources of data, including references to previously published work, datasets, and any other resources used in the research.

2. Plagiarism and Ethical Conduct

• Plagiarism: Plagiarism in any form, including self-plagiarism, is not tolerated. All manuscripts are subject to plagiarism detection tools to ensure originality.

• Fabrication and Falsification: Authors must not fabricate or manipulate research data or results. The integrity of research data must be preserved.

• Ethical Approval: For studies involving humans or animals, authors must include ethical approval from a recognized ethics committee. Authors should provide a statement of ethical approval when submitting their manuscripts.

• Conflict of Interest: Authors, reviewers, and editors must disclose any potential conflicts of interest. This includes financial, personal, or professional interests that could influence the research or the publication process.

3. Peer Review Process

• Double-Blind Peer Review: All manuscripts are subjected to a double-blind peer review process to ensure objective evaluation. Reviewers’ identities are not disclosed to authors, and authors’ identities are not disclosed to reviewers.

• Fair and Constructive Feedback: Reviewers are expected to provide unbiased, fair, and constructive feedback based on the scientific merit of the manuscript. Reviewers should not engage in personal criticism of the authors.

• Timeliness: Reviewers should complete their reviews within the agreed-upon timeframe. If a reviewer is unable to meet the deadline, they should inform the editorial office immediately.

4. Editorial Responsibilities

• Editorial Independence: The editorial board makes decisions based solely on the scientific merit of the manuscripts, without influence from external parties.

• Confidentiality: Editors must maintain confidentiality of all manuscripts under consideration. Manuscripts should not be disclosed or discussed with anyone other than the reviewers and relevant editorial staff.

• Decision Making: Editors are responsible for making the final decision on manuscript acceptance, rejection, or revisions, based on reviewers' feedback. Editors should provide transparent and detailed justifications for decisions.

• Corrections and Retractions: If errors or misconduct are discovered in published articles, the journal is committed to issuing corrections or retractions as appropriate to maintain the integrity of the scientific record.

5. Ethical Considerations for Reviewers

• Impartiality: Reviewers should evaluate manuscripts based on scientific merit, not personal relationships or biases.

• Confidentiality: Reviewers must treat all manuscripts as confidential documents and must not share or discuss the content with anyone else.

• Conflict of Interest: Reviewers should not agree to review manuscripts in which they have a conflict of interest.

• Timeliness: Reviewers should ensure that reviews are completed within the specified timeframe. If additional time is required, they should inform the editorial office in advance.

6. Copyright and Licensing

Copyright Ownership

• Authors retain the copyright to their work, but by submitting their manuscript to the International Journal of Pharmaceutical Science and Medicine, they grant the journal an exclusive license to publish, distribute, and promote the work.

• The journal allows authors to use, share, and distribute their work under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). This license permits others to remix, tweak, and build upon the work non-commercially, as long as proper credit is given.

Creative Commons Licensing

• License: The International Journal of Pharmaceutical Science and Medicine operates under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which allows:

  • Others to share the work, as long as they attribute it to the original author.

  • Non-commercial use of the work (i.e., not for profit or commercial advantage).

  • Derivative works can be made, but they must be non-commercial and must credit the original author.

• Rights and Permissions: Authors and users of the content must comply with the terms of the CC BY-NC 4.0 license. Authors are encouraged to share their works freely with proper attribution to the original research.

• No Commercial Use: The works published in this journal cannot be used for commercial purposes without prior permission from the copyright holder.

7. Malpractice

• Research Misconduct: Any case of research misconduct, including falsification, fabrication, or plagiarism, will result in immediate rejection of the manuscript and possible reporting to relevant authorities.

• Retraction: If a published article is found to contain falsified data, plagiarism, or other unethical practices, it will be retracted, and a notice of retraction will be issued.

• Complaint Resolution: Any ethical concerns, complaints, or disputes regarding publications will be reviewed by the editorial board, and appropriate action will be taken.

8. Contact Information

For any inquiries or complaints regarding publication ethics, copyright, or licensing, please contact:

• Email: info@pharmedicopublishers.com

• Phone: +91 9336570820